SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 434.72 |
| Enterprise Value ($M) | 400.87 |
| Book Value ($M) | -40.13 |
| Book Value / Share | -1.18 |
| Price / Book | -10.83 |
| NCAV ($M) | -43.95 |
| NCAV / Share | -1.29 |
| Price / NCAV | -9.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.77 |
| Return on Assets (ROA) | -0.92 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.20 |
| Current Ratio | 7.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 196.76 |
| Assets | 200.57 |
| Liabilities | 240.71 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 82.71 |
| Operating Income | -65.54 |
| Net Income | -102.24 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -76.38 |
| Cash from Investing | -0.95 |
| Cash from Financing | 116.93 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock Inc. | 4.60 | -2.89 | |
| 13D/A | Arkin Moshe | 4.44 | ||
| 13G | Rtw Investments, Lp | 5.60 | ||
| 13G/A | Great Point Partners Llc | 8.49 | 0.00 | |
| 13G/A | Ra Capital Management, L.p. | 9.99 | 0.00 | |
| 13G/A | Menora Mivtachim Holdings Ltd. | 7.46 | -21.10 | |
| 13G/A | Stonepine Capital Management, LLC | 0.00 | -100.00 | |
| 13D | Monograph Capital Holdings Advisors, LLC | 5.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 177,200 | 547,645 | 32.36 | |
| 39,279 | 148,562 | 26.44 | |
| 35,980 | 95,237 | 37.78 | |
| 33,949 | 76,028 | 44.65 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TRVI – Trevi Therapeutics, Inc. | TSBX – Turnstone Biologics Corp. |
| TVTX – Travere Therapeutics, Inc. | VCEL – Vericel Corporation |
| VERA – Vera Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io